Coppell Advisory Solutions LLC purchased a new position in Ventas, Inc. (NYSE:VTR – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 6,272 shares of the real estate investment trust’s stock, valued at approximately $557,000.
Several other institutional investors and hedge funds have also made changes to their positions in VTR. Deutsche Bank AG raised its position in shares of Ventas by 0.7% in the fourth quarter. Deutsche Bank AG now owns 3,904,293 shares of the real estate investment trust’s stock valued at $302,114,000 after buying an additional 27,688 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in shares of Ventas by 2.5% during the fourth quarter. Bank of New York Mellon Corp now owns 2,868,962 shares of the real estate investment trust’s stock valued at $222,000,000 after buying an additional 70,459 shares during the period. Norges Bank acquired a new stake in Ventas during the fourth quarter worth approximately $474,571,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Ventas by 7.4% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,346,111 shares of the real estate investment trust’s stock worth $104,095,000 after acquiring an additional 92,236 shares during the last quarter. Finally, Sei Investments Co. grew its stake in Ventas by 3.3% in the 1st quarter. Sei Investments Co. now owns 660,428 shares of the real estate investment trust’s stock worth $54,010,000 after acquiring an additional 21,378 shares during the period. 94.18% of the stock is currently owned by hedge funds and other institutional investors.
Ventas Stock Performance
NYSE:VTR opened at $92.14 on Friday. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. The company has a market cap of $47.26 billion, a P/E ratio of 170.63, a P/E/G ratio of 3.59 and a beta of 0.70. Ventas, Inc. has a fifty-two week low of $66.38 and a fifty-two week high of $101.60. The firm’s 50 day moving average is $92.92 and its two-hundred day moving average is $87.80.
Analyst Ratings Changes
Several brokerages have weighed in on VTR. Raymond James Financial assumed coverage on Ventas in a report on Tuesday, June 16th. They issued an “outperform” rating and a $94.00 price target for the company. JPMorgan Chase & Co. lifted their price objective on Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a research report on Monday, May 11th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $100.00 target price on shares of Ventas in a research note on Tuesday, June 16th. Jefferies Financial Group increased their target price on Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a $110.00 price target on shares of Ventas in a research note on Tuesday, May 19th. Fourteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $99.00.
Check Out Our Latest Analysis on Ventas
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
See Also
- Five stocks we like better than Ventas
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
